公开(公告)号：US20240309078A1

公开(公告)日：2024-09-19

申请号：US18601222

申请日：2024-03-11

Applicant: Prothena Biosciences Limited

Inventor： Robin BARBOUR ,  Svetlana ALEXANDER ,  Mark E. RENZ ,  Shuning GAI ,  Tarlochan S. NIJJAR ,  Philip James DOLAN, III ,  Philip PAYNE

IPC: C07K16/18

CPC classification number: C07K16/18 ,  C07K2317/24 ,  C07K2317/565 ,  C07K2317/567 ,  C07K2317/76 ,  C07K2317/92

Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

公开(公告)号：US20220089702A1

公开(公告)日：2022-03-24

申请号：US16500251

申请日：2018-05-02

Applicant: Robin BARBOUR ,  Svetlana ALEXANDER ,  Mark E. RENZ ,  Shuning GAI ,  Tarlochan NIJJAR ,  Philip James DOLAN ,  Philip PAYNE ,  PROTHENA BIOSCIENCES LIMITED

Inventor： Robin BARBOUR ,  Svetlana ALEXANDER ,  Mark RENZ ,  Shuning GAI ,  Tarlochan S. NIJJAR ,  Philip James DOLAN, III ,  Philip PAYNE

IPC: C07K16/18

Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.